VolitionRX Statistics
NYSE: VNRXHealth CareBiotechnology: In Vitro & In Vivo Diagnostic SubstancesUSD
0.2266+0.0072 (+3.28%)
Market open · Delayed 15 min · as of Oct 9, 11:30 AM ET
VolitionRX by the numbers
VolitionRX has a market capitalization of $6.8 million based on 30.06M shares outstanding. With trailing EPS of $-3.80, VolitionRX is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 46.7% below its 50-day average and 91.3% below its 200-day average.
Average daily trading volume is 8.47M shares, or about $1.9 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
VNRX valuation vs. peer median
| Metric | VNRX | Peer median | Difference |
|---|---|---|---|
| Market cap | $6.81M | $7.13M | -4% |
| Avg. volume | 8.47M | 108.86K | +7682% |
Peer median across 8 companies: CDIO, TRIB, QCLS, BMRA, VRAX, ICCC, IMDX, NNNN.
Valuation
- Market cap
- $6.81M
- EPS (TTM)
- $-3.80
- Shares outstanding
- 30.06M
Price and trading
- Previous close
- 0.2194
- Open
- 0.2223
- Day range
- 0.22 – 0.23
- 52-week range
- 0.22 – 10.40
- 50-day moving average
- 0.4248
- Beta
- —
- Volume
- 350.08K
- Average volume
- 8.47M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 13, 2026
Additional statistics
- Market Cap
- 6.81M
- Forward Pe
- -0.27
- Eps
- -3.80
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 10.40
- Week52 Low
- 0.22
- Avg Volume
- 8.47M
- Shares Outstanding
- 30.06M
- Ma50
- 0.42
- Ma200
- 2.61
- Earnings Date
- Aug 13, 2026
- Pct From52w High
- -97.82%
- Pct From52w Low
- 3.00%